JSH-23
JSH-23是一种NF-κB转录活性抑制剂,其对LPS刺激的RAW 264.7 中的核因子(NF)-κB 转录活性具有抑制作用,IC50为 7.1 μM,并能干扰 LPS 诱导的 NF-κB核转位,而不影响 IκB 降解。
-
货号:
TK0346 -
规格:
- 1mg
- 2mg
- 5mg
-
价格:
¥0.00
JSH-23是一种NF-κB转录活性抑制剂,其对LPS刺激的RAW 264.7 中的核因子(NF)-κB 转录活性具有抑制作用,IC50为 7.1 μM,并能干扰 LPS 诱导的 NF-κB核转位,而不影响 IκB 降解。
| CAS No. | 749886-87-1 |
| 生物活性 | JSH-23 is an NF-κB inhibitor which inhibits NF-κB transcriptional activity with an IC50 of 7.1 μM in lipopolysaccharide (LPS)-stimulated macrophages RAW 264.7. JSH-23 inhibits nuclear translocation of NF-κB p65 without affecting IκBα degradation. |
| 分子式 | C16H20N2 |
| 分子量 | 240.34 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存条件 | Powder -20°C 3 years |
| 溶解性数据 | DMSO : ≥ 56 mg/mL (233.00 mM) |
| 体内研究 | JSH-23 (1 mg/kg, 3 mg/kg; orally administered; daily; for 2 weeks) significantly reverses the nerve conduction and nerve blood flow deficits seen in diabetic rats. |
| 体外研究 | JSH-2 (1-300 μM; 24 hours) at <100 μM does not show significant cytotoxic effects on the RAW 264.7 cells. Nuclear amount of NF-κB p65 is markedly increased upon exposure to LPS for 1 h. Treatment of JSH-23 (30 μM; 1 hours) to LPS- stimulated RAW 264.7 cells decreases nuclear content of NF-κB p65 in a dose-dependent manner. |
| 纯度及产品资料 | 98% |